Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC

Clinical trial NCT06601309 · RECRUITING

Trial details

NCT number: NCT06601309
Sponsor: Fujian Medical University Union Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2024-07-11
Primary completion: 2026-07-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.